These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23860898)

  • 1. Effects of a 12-week aerobic training on glycemic control in type 2 diabetes mellitus male patients.
    Tomar RH; Hashim MH; Al-Qahtani MH
    Saudi Med J; 2013 Jul; 34(7):757-9. PubMed ID: 23860898
    [No Abstract]   [Full Text] [Related]  

  • 2. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus.
    Artha IMJR; Bhargah A; Dharmawan NK; Pande UW; Triyana KA; Mahariski PA; Yuwono J; Bhargah V; Prabawa IPY; Manuaba IBAP; Rina IK
    Vasc Health Risk Manag; 2019; 15():149-157. PubMed ID: 31239693
    [No Abstract]   [Full Text] [Related]  

  • 3. Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study.
    Kipnes MS; Krosnick A; Rendell MS; Egan JW; Mathisen AL; Schneider RL
    Am J Med; 2001 Jul; 111(1):10-7. PubMed ID: 11448655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic effects of long term exercise in Type 2 Diabetes patients.
    Cauza E; Hanusch-Enserer U; Strasser B; Kostner K; Dunky A; Haber P
    Wien Med Wochenschr; 2006 Sep; 156(17-18):515-9. PubMed ID: 17041809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of glycemic control in patients with type 2 diabetes mellitus in Chinese communities: a cross-sectional study.
    Shan S; Gu L; Lou Q; Ouyang X; Yu Y; Wu H; Bian R
    Clin Exp Med; 2017 Feb; 17(1):79-84. PubMed ID: 26695015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor-gamma agonist increases both low-density lipoprotein cholesterol particle size and small high-density lipoprotein cholesterol in patients with type 2 diabetes independent of diabetic control.
    Bavirti S; Ghanaat F; Tayek JA
    Endocr Pract; 2003; 9(6):487-93. PubMed ID: 14715475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).
    Davis TM; Cull CA; Holman RR;
    Diabetes Care; 2001 Jul; 24(7):1167-74. PubMed ID: 11423497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased peripheral blood mitochondrial DNA content is related to HbA1c, fasting plasma glucose level and age of onset in type 2 diabetes mellitus.
    Xu FX; Zhou X; Shen F; Pang R; Liu SM
    Diabet Med; 2012 Jul; 29(7):e47-54. PubMed ID: 22211946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Intensity Interval Training in Patients with Type 2 Diabetes Mellitus: a Systematic Review.
    da Silva DE; Grande AJ; Roever L; Tse G; Liu T; Biondi-Zoccai G; de Farias JM
    Curr Atheroscler Rep; 2019 Feb; 21(2):8. PubMed ID: 30712240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
    Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS
    Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of micronised Fenofibrate in type 2 diabetes mellitus subjects with good glycemic control.
    Tan CE; Chew LS; Tai ES; Chio LF; Lim HS; Loh LM; Shepherd J
    Atherosclerosis; 2001 Feb; 154(2):469-74. PubMed ID: 11166781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes.
    Erdman DM; Cook CB; Greenlund KJ; Giles WH; El-Kebbi I; Ryan GJ; Gallina DL; Ziemer DC; Dunbar VG; Phillips LS
    Diabetes Care; 2002 Jan; 25(1):9-15. PubMed ID: 11772894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of five-element gymnastics in glucose and lipid control in Taiwanese patients with type 2 diabetes.
    Huang CL; Tai YK; Yang YH; Wang RH
    Res Nurs Health; 2012 Aug; 35(4):419-29. PubMed ID: 22495908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study.
    Dailey GE; Mohideen P; Fiedorek FT
    Clin Ther; 2002 Sep; 24(9):1426-38. PubMed ID: 12380634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin. A multicenter, randomized, double-blind, placebo-controlled trial.
    Yale JF; Valiquett TR; Ghazzi MN; Owens-Grillo JK; Whitcomb RW; Foyt HL
    Ann Intern Med; 2001 May; 134(9 Pt 1):737-45. PubMed ID: 11329231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial.
    Sigal RJ; Kenny GP; Boulé NG; Wells GA; Prud'homme D; Fortier M; Reid RD; Tulloch H; Coyle D; Phillips P; Jennings A; Jaffey J
    Ann Intern Med; 2007 Sep; 147(6):357-69. PubMed ID: 17876019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid response to pioglitazone in diabetic patients: clinical observations from a retrospective chart review.
    King AB; Armstrong DU
    Diabetes Technol Ther; 2002; 4(2):145-51. PubMed ID: 12079617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Triglyceride/HDL Ratio and Triglyceride Glucose Index as Predictors of Glycemic Control in Patients with Diabetes Mellitus Type 2.
    Babic N; Valjevac A; Zaciragic A; Avdagic N; Zukic S; Hasic S
    Med Arch; 2019 Jun; 73(3):163-168. PubMed ID: 31404127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciprofibrate effects on carbohydrate and lipid metabolism in type 2 diabetes mellitus subjects.
    Hernández-Mijares A; Lluch I; Vizcarra E; Martínez-Triguero ML; Ascaso JF; Carmena R
    Nutr Metab Cardiovasc Dis; 2000 Feb; 10(1):1-6. PubMed ID: 10812581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes.
    Hanefeld M; Brunetti P; Schernthaner GH; Matthews DR; Charbonnel BH;
    Diabetes Care; 2004 Jan; 27(1):141-7. PubMed ID: 14693980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.